drugset / Trial / NCT05423249
Treatment of Non-Anemic Iron Deficiency in Pregnancy
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective is to investigate the treatment of non-anemic iron deficiency (NAID) and the impact on development of anemia later in pregnancy. Anemia in the third trimester has been identified as a risk factor for maternal and fetal morbidity that might lead to mortality. Due to the high incidence of NAID in pregnancy, there is an opportunity for early screening and treatment to decrease progression to anemia. The primary aim of this study is to establish if treatment of NAID will result in higher third trimester hemoglobin values and decrease incidence of anemia at term.
Timeline
- Start
- 2022-08-12
- Primary completion
- 2024-11-01
- Completion
- 2024-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 325 mg | Oral |
| Subject | Vitamin C | Other / unclassified | 500 mg | Oral |
| Background | Docusate Sodium | Unknown | 100 mg | Oral |
| Background | Prenatal | Unknown | — | Oral |